Biontech plans to examine mRNA technology for malaria vaccines
Pharmaceutical company Biontech plans to create a vaccine for malaria based on the same mRNA technology as the firm's vaccine for covid-19, which the German company developed in collaboration with Pfizer.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
German firm Biontech, which in collaboration with Pfizer has developed one of the most widely-used coronavirus vaccines, now plans to create a vaccine against malaria.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
EMA currently sees no need for Covid booster jab
For subscribers
Pfizer and Biontech expand study of vaccines for children
For subscribers
